Genitrix has launched a scheme to help vet practices generate revenue through increasing sales of its canine mobility product, C2Collaplex. The scheme offers a money-back guarantee if clients and practices don’t see clear benefits from using C2Collaplex…

Genitrix has launched a new system called Osteokine, which produces Platelet-Rich-Plasma (PRP). PRP, an autologous solution containing therapeutically significant concentrations of platelets, is known to accelerate the healing of injuries and is already…

Genitrix has announced that HY-50 Vet^®, a sodium hyaluronate treatment for equine joints, has now been authorised for intravenous (IV) use.

Available until now for intra-articular (IA) use only, the company says HY-50 delivers the highest concentration…